Current role
Jannik Andersen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jannik Andersen
Tango Therapeutics, Inc. reported in an 8-K filed August 7, 2023 that Jannik Andersen was appointed Chief Scientific Officer, effective October 9, 2023.
“Jannik Andersen Ph.D., currently Head of Biology, will assume the role of Chief Scientific Officer, effective October 9.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Tango Therapeutics, Inc. (TNGX)
SEC 8-K
Current2023-10-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tango Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Malte Peters CEO, Board Member
- Malte Peters, M.D. CEO
- Barbara Weber Chairman
- Barbara Weber, M.D. Chairman
- Matthew Gall CFO
- Douglas Barry General Counsel
- Jessica Newcomb Chief Accounting Officer
- James B. Avery Board Member
- John Ketchum Board Member
- Lesley Ann Calhoun Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.